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Epigenetic Control of Cell Cycle-Dependent Histone Gene Expression
Is a Principal Component of the Abbreviated Pluripotent Cell Cycle
Ricardo Medina,a Prachi N. Ghule,a Fernando Cruzat,b A. Rasim Barutcu,a Martin Montecino,c Janet L. Stein,a* Andre J. van Wijnen,a
and Gary S. Steina*
Department of Cell Biology and Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts, USAa; Department of Biochemistry and Molecular
Biology, Faculty of Biological Sciences, Universidad de Concepción, Concepción, Chileb; and Centro de Investigaciones Biomédicas, Facultad de Ciencias Biológicas y
Facultad de Medicina, Universidad Andrés Bello, Santiago, Chilec
Self-renewal of human pluripotent embryonic stem cells proceeds via an abbreviated cell cycle with a shortened G1 phase. We
examined which genes are modulated in this abbreviated period and the epigenetic mechanisms that control their expression.
Accelerated upregulation of genes encoding histone proteins that support DNA replication is the most prominent gene regula-
tory program at the G1/S-phase transition in pluripotent cells. Expedited expression of histone genes is mediated by a unique
chromatin architecture reflected by major nuclease hypersensitive sites, atypical distribution of epigenetic histone marks, and a
region devoid of histone octamers. We observed remarkable differences in chromatin structure—hypersensitivity and histone
protein modifications—between human embryonic stem (hES) and normal diploid cells. Cell cycle-dependent transcription
factor binding permits dynamic three-dimensional interactions between transcript initiating and processing factors at 5= and 3=
regions of the gene. Thus, progression through the abbreviated G1 phase involves cell cycle stage-specific chromatin-remodeling
events and rapid assembly of subnuclear microenvironments that activate histone gene transcription to promote nucleosomal
packaging of newly replicated DNA during stem cell renewal.
Human embryonic stem (hES) and induced pluripotent stem(iPS) cells maintain an undifferentiated state, are competent
to proliferate indefinitely, and possess the ability to differentiate to
all three germ layers (25, 33, 42, 45, 51, 52, 54, 60). The unique
ability to self-renew and to give rise to any cell type of an organism
reflects the therapeutic potential of pluripotent stem cells in re-
generative medicine. Human ES and iPS cells have an abbreviated
G1 phase and lack a classical restriction (R) point that normally
controls commitment for progression into S phase (3, 4, 23, 24).
In contrast, proliferation of somatic cells is linked to growth fac-
tor-dependent passage through the R point in G1 phase (43, 44).
The precise mechanisms by which cell cycle kinetics are modu-
lated as cells switch between pluripotent and phenotype-commit-
ted states are complex and remain to be established. Key cell cycle-
related gene-activating events that occur between mitosis and S
phase must be accelerated in the pluripotent state relative to those
in phenotype-committed cells. More importantly, the absence of
an R point in pluripotent cells necessitates reliance on other G1/S-
phase-related gene-regulatorymechanisms to control entry into S
phase. To understand molecular events at the G1/S-phase transi-
tion in pluripotent embryonic stem cells, it is necessary to identify
genes that can bemechanistically examined for chromatin remod-
eling that accompanies gene activation.
There are fundamental architectural modifications in genome
configurations during the abbreviated self-renewal cell cycle of
pluripotent hES cells to establish competency for DNA replica-
tion. As hES cells exit mitosis during self-renewal, chromosome
decondensation and immediate assembly of chromatin-related
nuclear microenvironments essential for gene expression (e.g.,
histone locus bodies, or HLBs) are expedited (23). Another accel-
erated principal chromatin-remodeling event in hES cells is linked
to the induction of DNA replication and concomitant packaging
of newly replicatedDNA into chromatin by histone octamers (i.e.,
composed of two heterodimers of the core histone proteins
H4-H3 and H2A-H2B). Chromatin-related mechanisms control
gene activation necessary for S-phase entry by rendering promot-
ers selectively and rapidly accessible to regulatory factors. These
events in the abbreviated G1 phase of hES cells are temporally
interposed between dynamic chromatin-remodeling events at the
M/G1 and G1/S transitions.
Maintenance of an open chromatin structure is essential for
the pluripotent state. For example, depletion of the chromatin-
remodeling factor geneChd1 in mouse ES cells results in accumu-
lation of heterochromatin and loss of pluripotency (20). The tran-
scription factors Oct4, Sox2, and Nanog constitute the core
regulatory circuitry of embryonic stem cells and sustain pluripo-
tency by activating a great number of genes (10, 11, 34, 50). These
pluripotency factors also repress cell lineage-specific regulators to
maintain the undifferentiated state (5, 8, 9, 29, 31, 46). To retain
options for differentiation into all cell types, the chromatin of
undifferentiated ES cells is transcriptionally permissive, with pro-
nounced sensitivity to nucleases and limited heterochromatiniza-
tion, as well as highly dynamic binding of structural proteins
(e.g., histones H2A and H2B, HP1), general transcription factors
(e.g., GTF2a1, GTF2b), and chromatin-remodeling factors (e.g.,
Smarca4, Chd1) (16, 35). Upon differentiation of ES cells, chro-
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matin structure becomesmore compact and repressive (1, 16, 49).
In contrast to the gene-selective chromatin remodeling that oc-
curs during the cell cycle on a “mixed background” of euchroma-
tin and heterochromatin in committed cells, active G1 phase-re-
lated changes in chromatin architecture in ES cells must be
achieved on a predominantly euchromatin background. Thus,
identifying representative genes that are upregulated at the onset
of S phase and remodeled in an open chromatin configuration is a
significant priority.
The very short G1 phase of ES cells is expected to temporally
compress chromatin remodeling of genes that are transcription-
ally induced at the G1/S-phase transition. Therefore, it is impor-
tant to establish how chromatin structure is locally reorganized to
support activation of genomic loci that are essential for S-phase
progression, while cells decondense chromatin following mitotic
division in anticipation of accelerated S-phase entry. Equally im-
portant, pluripotent cells must rely on R-point-independent
gene-regulatory mechanisms to achieve competence for S-phase
entry. Thus, it is necessary to characterize genes that are induced at
the G1/S-phase transition to understand how pluripotent cells
commit to chromatin duplication. Significantly, we find that ac-
tivation of genes encoding histones—the very proteins that pack-
ageDNA as chromatin and convey epigenetic regulatory informa-
tion—is themost prominent gene regulatory program at the onset
of S phase in human ES cells. This induction is mediated by active
remodeling of chromatin, dynamic recruitment of gene regula-
tory factors, and epigenetic marking of nucleosomes that are dis-
tinctly organized at human histone loci. These findings establish a
histone gene-selective reconfiguration of chromatin architecture
that proceeds in parallel with decondensation of chromatin as
cells exit frommitosis through an abbreviated G1 phase in prepa-
ration for S phase in pluripotent human ES cells.
MATERIALS AND METHODS
Cell culture. Human embryonic stem cell line H9 (WA09; WiCell Re-
search Institute, Madison, WI) and human iPS cell lines A6 and D1 (25)
were maintained under nondifferentiated conditions in hESC medium
(Dulbecco modified Eagle medium–nutrient mixture F-12, 20% Knock-
Out serum replacement, 1 mM L-glutamine, 1% nonessential amino ac-
ids, 0.1 mM -mercaptoethanol [all from Gibco/Invitrogen, Carlsbad,
CA], 4 ng/ml -fibroblast growth factor [-FGF] [R & D Systems, Min-
neapolis, MN]) at 37°C with 5% CO2 in a humidified incubator. Cells
were routinely examined for stem cell markers and normal karyotype.
Pluripotent cells weremaintained on inactivatedmouse embryonic fibro-
blast-coated plates prepared as described before (3). Normal diploid
TIG-1 fibroblasts were cultured inNunclon surface dishes (Nunc, Roch-
ester, NY) andmaintained inMEM–10% fetal bovine serum (FBS), 2mM
L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (all from
Gibco/Invitrogen) at 37°C and 5% CO2 in a humidified incubator. Nor-
mal diploid IMR-90 fibroblasts were maintained in BME (Gibco/Invitro-
gen), 10% FBS (Atlanta Biologicals), 2 mM L-glutamine, 100 U/ml peni-
cillin, and 100g/ml streptomycin (both fromGibco/Invitrogen) at 37°C
and 5%CO2 in a humidified incubator. Normal diploidWI-38 fibroblasts
were maintained in MEM-EBSS (Gibco/Invitrogen), 10% FBS (Hy-
Clone), 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mMnonessential
amino acids, 100 U/ml penicillin, and 100 g/ml streptomycin (all from
Gibco/Invitrogen) at 37°C and 5% CO2 in a humidified incubator. Hu-
manES cells (H9) andTIG-1 fibroblastswere synchronized using nocoda-
zole (200 ng/ml and 50 ng/ml, respectively) for 16 h, and samples were
taken at different time points after release. NormalWI-38 fibroblasts were
synchronized by serum deprivation for 72 h, and samples were taken at
different time points after release in the same medium containing 20%
serum.
RNA isolation, cDNA synthesis, and real-time quantitative PCR.
Total RNA was either prepared using TRIzol reagent (Invitrogen) fol-
lowed by DNase I treatment (DNA-free RNA kit; Zymo Research, Irvine,
CA) or column purified using the RNeasy Plus minikit or the miRNeasy
minikit (Qiagen, Valencia, CA). Synthesis of cDNA was performed with
the SuperScript first-strand synthesis system III (Invitrogen). The relative
transcript level was determined by the CT method using the cycle
threshold (CT) obtained in the 7300 sequence detection system (Applied
Biosystems, Foster City, CA) and iTaq SYBR green supermix with ROX
(Bio-Rad Laboratories, Hercules, CA). The following primer pairs were
used for human transcripts: forHIST2H4 (histoneH4/n), AGCTGTCTA
TCG GGC TCC AG (forward) and CCT TTG CCT AAG CCT TTT CC
(reverse); forHIST1H3I (histone H3/f), ATG GCA CGA ACA AAG CAA
AC (forward) and GTA GCG GTG GGG CTT CTT (reverse); for CCNE2
(cyclin E2), CCGAAGAGCACTGAAAAACC (forward) andGAATTG
GCT AGG GCA ATC AA (reverse); for CCNB2 (cyclin B2), ACT GCT
CTG CTC TTG GCT TC (forward) and TTT CTC GGA TTT GGG AAC
TG (reverse).
Gene arrays. GeneChip human gene 1.0 ST arrays (Affymetrix, Santa
Clara, CA) were used to analyze total RNA isolated from hES cells and
normal human fibroblasts (TIG-1). These arrays interrogate 28,869 well-
annotated genes with 764,885 distinct probes and offer whole-transcript
coverage with multiple probes distributed across the full length of the
gene. DNA-free total RNA samples from synchronized hES cells in G1 or
S phase (1.5 or 4 h after release from a nocodazole [Sigma, St. Louis, MO]
block)were labeled and analyzed according to themanufacturer’s instruc-
tions at the Genomics Core Facility at University of Massachusetts Med-
ical School. Fold ratios (R values) were determined to assess the relative
expression of genes in G1 versus S phase.
Sensitivity to nucleases. Nuclease hypersensitivity was assessed by
digestion of human embryonic stem (hES) or normal diploid fibroblasts
(TIG-1 or IMR-90) nuclei with DNase I. Nuclei were isolated by Dounce
homogenization of cells in 10ml of RSB buffer (10mMTris-HCl, pH 7.4,
10 mM NaCl, 5 mM MgCl2) supplemented with 0.5% Nonidet P-40.
Nuclei were recovered by centrifugation at 1,000  g for 5 min at 4°C.
Nuclei were washed twice with RSB buffer and recovered by centrifuga-
tion as described before. Nuclei were then resuspended in RSB buffer
supplemented with 1 mM CaCl2 and incubated with increasing concen-
trations ofDNase I (DPRF;WorthingtonBiochemical Corporation, Lake-
wood, NJ) for 10 min at room temperature with gentle agitation. Reac-
tions were stopped by the addition of 150l of stop buffer (50mMEDTA
and 0.5% SDS). DNA was purified by standard phenol-chloroform-iso-
amyl alcohol extraction and completely digested with PstI/BamHI (New
England BioLabs, Ipswich, MA), electrophoresed in an 2% agarose gel in
1 TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.0), and trans-
ferred to Hybond-N membranes (GE Healthcare, Piscataway, NJ) ac-
cording to the manufacturer’s instructions. Southern blotting was per-
formed using a probe prepared by digesting a plasmid carrying the
HIST2H4 (histone H4/n) gene with XbaI/PstI and labeling using random
primers (Invitrogen) spanning the region between nucleotides 1,048
and 1,264 (probe, 831/1,264; see Fig. 2A) relative to the transcrip-
tional start site (TSS).
ChIP assays. For standard chromatin immunoprecipitation (ChIP)
assays, human ES cells and normalWI-38 fibroblasts were cross-linked at
room temperature in ESC medium or incomplete WI-38 medium with
formaldehyde for 10 min and 6 min, respectively. To increase the likeli-
hood of detecting occupancy of non-DNA binding proteins, we per-
formed dual cross-linking using two long-arm protein-protein cross-
linking agents: ethylene glycol-bis(succinimidyl succinate) (EGS) and
dimethyl 3,3=-dithiobispropionimidate · 2HCl (DTBP) (Thermo Scien-
tific, Rockford, IL). Human ES cells were separately incubated with EGS
or DTBP in hESC medium for 20 min at room temperature before the
addition of formaldehyde. Cross-linking was stopped by the addition of
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glycine for 5 min at room temperature. Cells were harvested in ice-cold
PBS containing 1 complete protease inhibitor (Roche Applied Science,
Indianapolis, IN), 1 phosphatase inhibitor cocktail I (Calbiochem,
Gibbstown, NJ), 1 phosphatase inhibitor cocktail II (Calbiochem), and
20 mM sodium butyrate (Sigma). Cells were rapidly frozen in liquid ni-
trogen and stored at 80°C until use. Cell pellets were resuspended in
buffer 1 (50mMHEPES-KOH, pH 7.5, 140mMNaCl, 1mMEDTA, 10%
glycerol, 0.5% Nonidet P-40, 0.25% Triton X-100, 1 protease inhibi-
tors), and after centrifugation the pellet was resuspended in buffer 2 (10
mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1
protease inhibitors). The pelleted nuclei were then resuspended in buffer
3 (10mMTris-HCl, pH 8.0, 100mMNaCl, 1 mMEDTA, 0.5 mMEGTA,
0.1% sodium deoxycholate, 0.5%N-lauroylsarcosine, 1 protease inhib-
itors) and sonicated with a Misonix ultrasonic liquid processor S-4000
(QSonica, LLC, Newtown, CT). Chromatin was recovered from the su-
pernatant, and the efficiency of sonication was analyzed by electrophore-
sis on an agarose gel tomonitor the size of shearedDNA (between 250 and
650 bp). Chromatin was aliquoted, rapidly frozen in liquid nitrogen, and
stored at80°C until use. ChIP assays were initiated by diluting chroma-
tin either in buffer FA (50 mM HEPES-KOH, pH 7.5, 140 mM NaCl, 1
mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 1
protease inhibitors) for H3K4me3 (Abcam, Cambridge, MA) antibody or
in sonication buffer 3 for the remaining antibodies. The following anti-
bodies were used per 100 g chromatin: HINFP (5 l of 802K rabbit
polyclonal antiserum) (40), RNA polymerase II (pol II) (2.5l of 8WG16
mouse monoclonal IgG2a, ascites fluid; catalog no. MMS-126R; Covance
[Princeton, NJ]), p220NPAT (5 l of rabbit polyclonal serum kindly pro-
vided by J. Wade Harper, HarvardMedical School [32], or 5g of mouse
monoclonal IgG2b; catalog no. 611344; BD Biosciences [San Jose, CA]),
LSM10 (2 g of mouse monoclonal IgG2a; catalog no. BMR00504; Bio
Matrix Research Inc. [Nagareyama City, Chiba, Japan]), LSM11 (10l of
rabbit affinity-purified antibody [47]), FLASH (12 l of rabbit affinity-
purified antibody [7]), SLBP (10 l of rabbit polyclonal antibody [17]),
CPSF73 (1g of rabbit affinity-purified antibody; catalog no. A301-091A;
Bethyl Laboratories, Inc. [Montgomery, TX]), histone H3 (5 g of rabbit
polyclonal IgG; catalog no. ab1791; Abcam), H3K4me3 (5 l of rabbit
polyclonal serum; catalog no. 39159; Active Motif [Carlsbad, CA], or 20
g of mouse monoclonal IgG2b; catalog no. ab1012; Abcam), H3K9ac (5
g of rabbit polyclonal IgG; catalog no. ab4441; Abcam), H3K27me3 (5
g of rabbit polyclonal IgG; catalog no. 07-449; Millipore [Billerica,
MA]), H4K12ac (5 l of rabbit polyclonal serum; catalog no. 07-595;
Millipore), and H4K16ac (5 g of rabbit polyclonal serum; catalog no.
07-329;Millipore). After incubation with the antibodies overnight at 4°C,
chromatin-antibody complexes were recovered by incubating with pre-
blocked protein A/G-agarose beads (Santa Cruz Biotechnology, Santa
Cruz, CA) for 2 h at 4°C on a rotatingwheel. Beadswerewashed,DNAwas
eluted, and cross-links were reversed. DNA was recovered by ethanol
precipitation and analyzed by quantitative PCR (qPCR). ChIP results
were expressed as percent input. Alternatively, DNA concentration was
quantified by fluorometry (Qubit, Invitrogen), and all samples were ad-
justed to the same concentration. DNA (0.5 ng) was analyzed by qPCR
and expressed as fold enrichment (2[ChIP CT  input CT]). The following
primer pairs were used for H4: primer 1 (648 to519) (forward, ACG
TCC ATG AGA AAG CTT GG; reverse, CAG GTT CGC CAT AAT TCC
TG); primer 2 (412 to323) (forward, ATAAGCACGGCTCTGAAT
CC; reverse, ATA AGC ACG GCT CTG AAT CC); primer 3 (152 to
73) (forward, ATA AGC ACG GCT CTG AAT CC; reverse, ATA AGC
ACG GCT CTG AAT CC); primer 4 (4 to 69) (forward, ATA AGC
ACG GCT CTG AAT CC; reverse, CCT TTG CCT AAG CCT TTT CC);
primer 5 (50 to 177) (forward, CCT TTG CCT AAG CCT TTT CC;
reverse, CCT TTG CCT AAG CCT TTT CC); primer 6 (276 to 369)
(forward, CCT TTG CCT AAG CCT TTT CC; reverse, CCT TTG CCT
AAGCCT TTT CC); primer 7 (348 to473) (forward, CCT TTGCCT
AAG CCT TTT CC; reverse, CCT TTG CCT AAG CCT TTT CC); primer
8 (916 to1032) (forward, CCTTTGCCTAAGCCTTTTCC; reverse,
CCT TTG CCT AAG CCT TTT CC). The following primer pairs were
used for H3: primer 1 (678 to 559) (forward, AAG TGC CGG CTT
CTC TGA TA; reverse, CGC ATT GGT AGC GGT AAA GT); primer 2
(430 to251) (forward, CGC ATT GGT AGC GGT AAA GT; reverse,
CGC ATT GGT AGC GGT AAA GT); primer 3 (71 to37) (forward,
CGC ATT GGT AGC GGT AAA GT; reverse, ACT TGC GAG CTG TTT
GCT TT); primer 4 (4 to 78) (forward, ACT TGC GAG CTG TTT
GCT TT; reverse, ACT TGC GAG CTG TTT GCT TT); primer 5 (173
to 245) (forward, ACT TGC GAG CTG TTT GCT TT; reverse, ACT
TGCGAGCTGTTTGCTTT); primer 6 (349 to455) (forward, GCC
AAACGCGTCACT ATT ATG; reverse, GCC AAACGCGTCACT ATT
ATG); primer 7 (429 to 605) (forward, GCC AAA CGC GTC ACT
ATT ATG; reverse, GCC AAA CGC GTC ACT ATT ATG); primer 8
(1037 to 1210) (forward, GCC AAA CGC GTC ACT ATT ATG; re-
verse, GCC AAA CGC GTC ACT ATT ATG).
Immunofluorescence microscopy. Human ES H9 cells were grown
on coverslips, and immunofluorescence microscopy analysis was carried
out as described previously (21–23). Briefly, cells were fixed with 3.7%
formaldehyde for 10 min, permeabilized with 0.25% Triton X-100 for 20
min, and then treated with primary antibody for 1 h at 37°C, followed by
detection using the appropriate fluorescence-tagged secondary antibody.
The nuclei were counterstained with DAPI (4=,6-diamidino-2-phenylin-
dole). Cells were viewed under an epifluorescence Zeiss Axioplan 2 mi-
croscope, and images were captured using a Hamamatsu (C4742-95)
charge-coupled-device (CCD) camera and analyzed by Metamorph im-
aging software (Universal Imaging, West Chester, PA). The following an-
tibodies were used: monoclonal p220NPAT (mouse monoclonal, 1:1,000;
BD Biosciences, San Jose, CA), polyclonal p220NPAT (rabbit polyclonal,
1:1,000), polyclonal-T1270-p220NPAT (rabbit polyclonal, 1:500) (32, 61),
LSM11 (rabbit polyclonal, 1:500) (47), and RNA pol II (mouse monoclo-
nal clone 8WG16, 1:1,000; Covance, Princeton,NJ). Secondary antibodies
conjugated with Alexa Fluor dyes were all used at 1:800.
Proximity ligation assay. The proximity ligation assay protocol was
derived from the previously published chromosome conformation cap-
ture (3C) method (39) with modifications. Briefly, 4.6 million hES H9
cells were cross-linked and treated as described for ChIP assays. Nuclei
were digestedwith FatI (R0650,NewEnglandBioLabs) for 2 h at 55°C and
then overnight at 42°C. To reduce the background ligation frequency, the
ligation step was carried out in 80 separate reactions in which each
reaction mixture contained 0.5 genomic copy of DNA. Cross-links were
reversed, and DNA was purified by phenol-chloroform extraction fol-
lowed by ethanol precipitation. To control for primer efficiency and to
serve as a random ligation control, a bacterial artificial chromosome
(BAC) (RP11-1118G19; BACPAC) spanning the histoneHIST2H4 region
was used. The BAC template was prepared in the same fashion as the hES
cell template but without the cross-link step. The results of the assays
represent data obtained from two different sets of ligation reactions where
two different PCRs were performed in triplicate for each data point for
each sample. The PCR products were separated in a 1% agarose gel and
quantified by the Gel-Quant software (www.gelquant.org). The following
primer pairs were used: FatI_H4_1_FW, GGA GAA CTG TTT TGT TTC
TTC CA; FatI_H4_1_RV, GGA CCG AGC CAC TGT ATT TTA G;
FatI_H4_2_FW, TCA ATC TGG TCC GAT ACT CTT GT; FatI_H4_
2_RV, CCT GAA TGT TGT CTC TCA AGA CC; FatI_H4_3_FW, AAG
GTG TTC CTG GAG AAT GTG AT; FatI_H4_3_RV, ACT CCT CAG
ATGAGCAAGTGGT; FatI_H4_4_FW, TTGCTCTTCTGGTGCAGT
ATA GG; FatI_H4_4_RV, AAT GAA AAC CTA AGG CTG CTT CT;
FatI_GDR2_1FW, TGA CCT CCA GAA TGG TAA GAG AA;
FatI_GDR2_2RV, TTG TCT AGG AGA GCT CAG TCC AC. Statistical
analyses of differences in ligation frequencies between theHIST2H4 gene
and a gene desert region (GDR)were evaluated using general linearmixed
models (36). Models were fit by restricted maximum likelihood estima-
tion (12) using the SAS Proc Mixed procedure (48). In the presence of
significant differences among means, pairwise comparisons were made
usingTukey’s honestly significant difference (HSD)multiple-comparison
Medina et al.
3862 mcb.asm.org Molecular and Cellular Biology
 o
n
 Septem
ber 11, 2017 by UNIV O
F M
ASS M
ED SCH
http://m
cb.asm
.org/
D
ow
nloaded from
 
procedure (55) utilizing the estimated covariance matrix to account for
correlated observations. The distributional characteristics of outcome
measures were evaluated by applying the Kolmogorov-Smirnov good-
ness-of-fit test for normality (13) to residuals from fitted linear models
and by inspection of frequency histograms of these residuals. In some
cases, natural logarithms of outcomes were applied to better approximate
normally distributed residuals. All computations were performed using
the SAS version 9.1.3 (SAS Institute, 2006) and SPSS version 14 (SPSS,
Inc., 2005) statistical software packages. Statistical significance is defined
as present when associated P values are less than 0.05.
RESULTS
Histone gene expression is the most prominent genomic pro-
gram upregulated at the G1/S-phase transition in human em-
bryonic stem cells.Gene activation during the human embryonic
stem (hES) cell cycle requires gene-selective chromatin remodel-
ing. To identify model genes for mechanistic studies, we applied
an unbiased strategy to characterize which genes are maximally
upregulated at S-phase entry in hES cells. Gene expression profil-
ing reveals that 107 genes are elevated as synchronized hES H9
cells traverse from G1 to S phase. A substantial subset of these
genes, preferentially expressed in S phase, encode DNA replica-
tion-dependent histone proteins (n  40), including linker his-
toneH1 (n 4) and 36 core histones (H2A, 13; H2B, 9; H3, 7; H4,
7), corresponding to 61% of the full complement of human his-
tone genes that are modulated by 1.3-fold (Fig. 1A). Because
histones are required for packaging newly replicated DNA as
chromatin, this finding is consistent with biological expectations.
Many histone genes are upregulated by 2-fold or more in S
phase (e.g.,HIST1H3B andHIST1H2BM), and their expression is
roughly proportional to the total number of gene copies for each
subtype. Expression of only 17 genes is increased on average by
2-fold or more, and 15 of these are histone genes. As anticipated,
none of the DNA replication-independent histone gene variants
exhibits significant S-phase-related changes in mRNA levels (e.g.,
H1FX). Only two nonhistone genes are increased by 2-fold or
more in hES cells:MDM2 (2.1-fold), which encodes a protein that
antagonizes the growth suppression function of p53 (6, 18, 19,
30), and a pseudogene (ENST00000354652) of unknown rele-
vance. We also detected 65 other nonhistone genes that showed
elevated expression, but none of these were modulated by more
than 2-fold in hES cells. As expected, no histone genes were found
to have decreased expression in S phase compared to G1 phase in
hES cells (53 nonhistone genes were found to have decreased ex-
pression). For comparison, in normal human fibroblasts there are
only 22 histone genes and as many as 113 nonhistone genes that
exhibit elevated expression (Fig. 1A and B). These results demon-
strate that histone genes are the most prominently modulated
genes during the G1/S-phase transition in human embryonic stem
cells.
Histone gene expression in pluripotent cells is supported by
nuclease hypersensitivity and association of the transcription
factor HINFP and RNA polymerase II with histone H4 loci. Be-
cause histone gene expression is the most prominent gene regula-
tory event during the transition fromG1 to S phase in hES cells, we
defined the transcriptional mechanisms that control a representa-
tive histone H4 gene (HIST2H4 or H4/n gene). Analysis of nu-
clease sensitivity (56) of the genomic histone HIST2H4 locus to
DNase I reveals changes in chromatin structure that accompany
increased histone gene expression in hES cells. There are striking
hypersensitive sites (HSS) at the promoter (nucleotide [nt]
130), transcriptional start site (nt1), coding region (nt290),
and beyond the 3= end of the histoneH4 gene (nt490) (Fig. 2A).
Normal human TIG-1 and IMR-90 fibroblasts show HSS at the
same location (Fig. 2A), but they are significantlymore resistant to
DNase I digestion, even at higher nuclease concentrations (Fig.
2A). Thus, in hES cells the entire histone H4 gene locus, including
its 5= and 3= flanking regions, is in a more open and highly acces-
sible chromatin conformation.
Enhanced histone H4 gene expression in pluripotent hES cells
is mediated by association of the histone H4 gene-specific tran-
scription factor HINFP and RNA polymerase II with the histone
HIST2H4 gene. Chromatin immunoprecipitation (ChIP) analysis
shows that HINFP and RNA pol II are both present at the histone
H4 gene in hES cells (Fig. 2B). HINFP binds distal to RNApol II in
the histone H4 gene promoter: maximal HINFP binding is cen-
tered at its cognate element (site II) in the proximal promoter,
while RNA pol II is associated with the transcriptional start site
(TSS), as well as with downstream sequences. ChIP results with
two distinct induced pluripotent stem (iPS) cell lines (iPS A6 and
iPSD1) (25) and a normal human lung fibroblast cell line (WI-38)
show that both HINFP and RNA pol II tandemly associate with
the histone H4 gene promoter as in hES H9 cells (Fig. 3A). The
relative association of RNA pol II and HINFP in WI-38 is less
pronounced, consistent with the smaller fraction of WI-38 cells
progressing through S phase. Therefore, HINFP and RNA pol II
association with the histone H4 gene is a general property of pro-
liferating cells in the pluripotent state.
The HINFP motif in site II is located directly upstream (	10
bp, or one DNA helix turn) of the TATA box, which suggests a
molecular mechanism by which HINFP together with the protein
FIG 1 Gene expression profiling during the G1/S-phase cell cycle transition.
(A)Comparativemicroarray analysis of genes exhibiting1.2-fold differences
in expression in human embryonic stem (hES) cells or normal human fibro-
blasts (TIG-1). Expression profiling was performed using GeneChip human
gene 1.0 ST arrays from Affymetrix. (B) Venn diagrams showing the numbers
of genes with increased and decreased expression during the G1/S-phase tran-
sition in hES versus TIG-1 cells.
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complex of general transcription factors interacting with the
TATA box may mediate RNA polymerase II recruitment. Impor-
tantly, our data show that strong interactions of HINFP and RNA
pol II occur within the region of the histone H4 locus that is
maximally accessible to DNase I, reflecting a highly open chroma-
tin structure at the TSS. To test whether HINFP and RNA pol II
cooccupancy is observed for other histone genes or is limited to
HINFP-dependent histone H4 genes, we assessed RNA pol II
binding to a HINFP-independent histone H3 gene (HIST1H3I or
H3/f gene). ChIP analysis shows that RNA pol II is present at the
TSS of the histone H3 gene in hES cells but that HINFP binding is
negligible (Fig. 3D). Our data suggest that binding of RNA pol II
to histone gene promoters in hES cells is characteristic of ex-
pressed histone genes. However, HINFP supports the positioning
of RNA pol II only near the TSS of histone H4 and not H3 genes.
Binding of RNA pol II to other histone genes may be mediated by
other histone gene-specific transcription factors.
Active epigenetic histone modifications mark dynamically
transcribed histone genes in pluripotent cells. The epigenetic
landscape of chromatin at the histone genes in human pluripo-
tent cells is reflected by distinct covalent modifications of his-
tone proteins related to transcriptional activation. We per-
formed ChIP analysis for trimethylation of histone H3 lysine 4
(H3K4me3) and acetylation of histone H3 lysine 9 (H3K9ac) as
representative active marks, while trimethylation of histone H3
lysine 27 (H3K27me3) was monitored as a repressive mark. In
all three pluripotent stem cells (hES H9, iPS A6, and iPS D1) we
detected high levels of H3K4me3 and H3K9ac both upstream
and downstream of the TSS (Fig. 3B) of the histone H4 gene. In
each case, we observed decreased levels of these marks at the
TSS. This finding is indicative of a nucleosome-free region at
the TSS, consistent with previous observations in human can-
cer cell lines (27, 41). Similar results were obtained for the
histone H3 gene (Fig. 3E). In contrast, the repressive mark
H3K27me3 was found to be minimally present at both H4 and
H3 loci in all three pluripotent stem cells and hES cells, respec-
tively, as expected from an actively transcribed gene contained
within an open chromatin context (Fig. 3C and F). We note
FIG 2 Chromatin architecture of the human histone H4 gene in hES cells. (A) DNase I hypersensitivity at the human histone H4 gene (HIST2H4). Nuclei
were isolated from hES cells (lanes 4 to 6) and normal diploid fibroblasts (TIG-1 and IMR-90; lanes 7 to 9 and 10 to 12, respectively), and DNA was
prepared as described in Materials and Methods. Naked genomic DNA from hES cells digested with increasing amounts of DNase I was used as a control
(lanes 1 to 3). The positions of the DNase I hypersensitive sites (HSSs) are shown on the right. A schematic representation of the human histone H4 gene,
restriction sites, transcription start site, probe used in Southern blots, and HSSs (arrowheads) is shown on the left. Human ES cells show increased
nuclease sensitivity at lower DNase I concentrations than normal diploid fibroblasts (compare lane 6 with lanes 9 and 12); the asterisk (nt130, lane 5)
designates an HSS in hES cells that is observed only at short digestion times. (B) Chromatin landscape of the histone H4 gene in human pluripotent cells.
The top panel shows a schematic of the genomic organization of the human histone H4 gene. Transcriptional binding sites I and II, the set of primers (lines
1 to 8) used for analyses and their location, the HSSs (arrowheads), and the sequence representing the typical stem-loop structure found in histone
mRNAs are shown. The bottom panel shows chromatin immunoprecipitation analysis for RNA pol II and HINFP at the human histone H4 gene in human
embryonic stem cells.
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FIG 3 Active chromatin marks at the human histone H4 and H3 gene loci in human pluripotent and normal diploid cells. (A) Interaction of RNA pol II and
HINFP with the human histone H4 gene (HIST2H4) in human pluripotent cells (hES H9, iPS A6, iPS D1) and normal fibroblasts (WI-38). The top panel shows
a schematic of the genomic organization of the human histone H4 gene as described in Fig. 2. Maximal interaction of HINFP (gray arrowheads) with the histone
H4 gene is distal to that of RNApol II (black arrowheads) in all three pluripotent cells and in normal fibroblasts (WI-38). The values obtained for ChIP antibodies
and control IgGs are represented, respectively, by continuous and dotted lines. (B) Chromatin immunoprecipitation analysis of epigenetic marks of the histone
H4 gene in human pluripotent cells and normal fibroblasts (WI-38). Solid lines represent the epigeneticmarksH3K4me3 (black) andH3K9ac (gray), and dotted
lines represent mouse or rabbit ChIP control IgGs for H3K4me3 (black) and H3K9ac (gray), respectively. (C) The human histone H4 gene lacks the epigenetic
repressive mark H3K27me3 in all three pluripotent cell lines (hES H9, iPS A6, and iPS D1). Solid lines represent the epigenetic mark (black) and dotted lines
represent rabbit ChIP control IgG (black) for H3K27me3. (D) Interactions of RNA pol II and HINFP with the human histone H3 gene (HIST1H3I) in hES H9
cells. The top panel shows a schematic of the genomic organization of the human histone H3 gene. The locations of primers (lines 1 to 8) used for ChIP analyses
and the typical stem-loop structure found in histone mRNAs are shown. Values obtained for ChIP antibodies and control IgGs are represented, respectively, by
continuous and dotted lines. (E) Chromatin immunoprecipitation analysis of epigenetic marks at the histone H3 gene in hES H9 cells. Solid lines represent the
epigenetic marks H3K4me3 (black) andH3K9ac (gray), and dotted lines represent mouse or rabbit ChIP control IgGs for H3K4me3 (black) andH3K9ac (gray),
respectively. (F) The human histone H3 gene lacks the epigenetic repressive mark H3K27me3 in hES cells. Solid lines represent the epigenetic mark (black) and
dotted lines represent rabbit ChIP control IgG (black) for H3K27me3.
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FIG 4 Selective occupancy of human histone genes during the pluripotent cell cycle. Human embryonic stem cells were synchronized in the G2/M phase of the
cell cycle by a nocodazole block and then released into the cell cycle. The top portion shows a schematic of ChIP primers relative to the genomic organization of
the human histone H4 and H3 genes as described in Fig. 2. (A) Relative mRNA levels of cell cycle markers in synchronized hES H9 cells. An increase in the levels
of histone H4 (solid line) and H3 (dashed line) RNAs and a decrease in cyclin E2 RNA (dotted line) confirm transition of cells from G1 to early S phase. (B)
Chromatin immunoprecipitation analysis of the human histoneH4 (left panel) andH3 (right panel) genes in hESH9 cells at the G1/S-phase boundary. (C) ChIP
analysis of the histoneH4 (left panel) andH3 (right panel) promoters during the cell cycle in hESH9 cells. Association ofHINFP (toppanels), the histone cofactor
p220NPAT (middle panels), and RNA pol II (bottom panels) with the histone H4 and H3 genes is shown. (D) Temporal changes in binding of proteins at the site
of maximal occupancy in the histone H4 locus during the hES cell cycle (around the TSS for RNA pol II and p220NPAT and around site II for HINFP). (E) ChIP
analysis of HINFP association with the histone H4 gene during the cell cycle in normal fibroblasts (left panel). HumanWI-38 cells were synchronized by serum
deprivation and then released into the cell cycle by serum stimulation. Histone H4 transcript profile (right panel) confirms synchrony of WI-38 cells.
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that H3K27me3 was clearly detected at the GATA6 and OSX
loci that are not expressed in hES cells (data not shown). We
also observed the presence of the active mark H3K4me3 in
fibroblasts (Fig. 3B, bottom panel), although we note a striking
difference in its association with the histone H4 locus com-
pared with that of pluripotent cells: we detected high levels of
H3K4me3 in the fibroblast cell line at the TSS, coding region,
and 3= end. These results indicate that the open chromatin
structure of the histone gene loci in pluripotent cells exhibits
transcriptionally permissive histone modifications.
Selective occupancy of human histone genes at the G1/S-phase
transition of the pluripotent cell cycle. The histone H4-specific
transcription factor HINFP and RNA pol II are recruited in a
temporal-spatial manner to the histoneH4 gene during the short-
ened G1 phase of pluripotent human ES and iPS cells. ChIP assays
were performed using mitotically synchronized hES H9 cells that
exhibit increased histone H4 and H3 and decreased cyclin E2
mRNA levels during progression from G1 to early S phase (Fig.
4A). The association of RNA pol II with the histone H4 promoter
and sequences downstream of the TSS increases in early S phase
FIG 5 Epigenetic landscape of human histone genes. Chromatin immunoprecipitation analysis was performedwith hES andWI-38 cells that were synchronized
in the G2/M phase by a nocodazole block and in G0 by serum deprivation, respectively (details in Fig. 4 legend). Covalent modifications of histone proteins
H3K4me3, H3K9ac, and total histone H3 (A and C) and H4K12ac, H4K16ac, and H3K27me3 (B and D) in hES cells at the human histone H4 and H3 genes are
shown. Covalent modifications of histone proteins H3K4me3 and histone H3 (E) and H4K12ac and H3K27me3 (F) in WI-38 cells at the histone H4 locus are
shown. Epigenetic marks normalized to total histone signal in hES cells (G) and fibroblasts (H) during the maximal occupancy of histone genes at mid-S phase
are also shown. The top panels show the location of ChIP primers for histone H4 and H3 genes as described in Fig. 2.
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FIG 6 Molecular events associated with the activation and processing of human histone H4 transcripts. (A) Colocalization of 5= and 3= regulatory factors in hES
cells. p220NPAT foci (green) are associatedwith the transcriptionalmachinery (RNApol II, top andmiddle panels, red) and 3=-end processingmachinery (LSM11,
lower panel, red) at histone gene clusters in humanH9 cells. DAPI staining (blue) is used to visualize the nucleus. Panels on the right representmagnified images
for each antibody andmerged channels from the left panel (white squares).Merged images show that p220NPAT foci, which denoteHLBs, colocalize (yellow)with
factorsmediating histone pre-mRNAprocessing at sites of histone gene transcription. (B)Chromatin immunoprecipitation analysis of 3=-end-processing factors
at H4 and H3 histone genes in human ES cells. Solid lines represent specific interactions above background IgG signal (dotted lines) of the 3=-end-processing
factors LSM10 (black, top), FLASH (black, bottom), LSM11 (gray, top), and SLBP (gray, bottom) with the histone H4 and H3 genes. (C) Schematic represen-
tations of binding of histone H4-specific gene regulatory factors to sites I and II and binding of RNA pol II are shown (37, 38, 40, 57). Modifications of histone
proteins upstream and downstream of the TSS and hypersensitivity to nucleases (HSSs; arrowheads) are also shown; nucleosomes located 1 kb upstream of the
TSS are devoid of active histone modifications (unpublished observations). Several 3=-end-processing factors and proteins involved in transcription of the
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(Fig. 4B, left panel). In contrast, HINFP binding is restricted to its
recognitionmotif within site II upstream from the TSS in both G1
and early S phase (Fig. 4B, left panel) and HINFP remains consti-
tutively bound during the entire cell cycle of hES cells (Fig. 4C, left
panel). Association of HINFP with the histone H4 gene was also
observed throughout the cell cycle of synchronized WI-38 cells,
though the signal was less pronounced than in hES cells (Fig. 4E,
left panel). Strikingly, while HINFP binds constitutively, RNA pol
II and p220NPAT, which is the essential CDK2-responsive coacti-
vator of HINFP, are both selectively recruited at the G1/S transi-
tion and exhibit increased association during S phase in hES cells
(Fig. 4C, left panel). Similarly, binding of RNApol II to the histone
H3 promoter and sequences downstreamof the TSSmirrors those
of the histone H4 at the G1/S-phase transition (Fig. 4B, right
panel) and during itsmaximal occupancy atmid-S phase (Fig. 4C,
right panel). HINFP occupancy at the histone H3 locus is negligi-
ble throughout the cell cycle of hES cells, consistent with results
from asynchronous cells (Fig. 3D). Temporal changes at the site of
maximal occupancy within the histone H4 locus during the cell
cycle of hES cells show that occupancy by RNA pol II and
p220NPAT follows a remarkably similar pattern, peaking when his-
tone H4 mRNA is at its highest level (Fig. 4D). Taken together,
these data demonstrate that a dynamic and selective increase in
protein-DNA interactions of the HINFP/p220NPAT coactivation
complex and RNA pol II occurs during induction of histone H4
gene expression at the G1/S-phase transition in hES cells.
Active epigenetic marks associate with histone genes during
the cell cycle of hES cells. Epigenetic posttranslational modifica-
tions of histone proteins accompany cell cycle-dependent modu-
lations in occupancy of RNA pol II and p220NPAT at the histone
H4 promoter. ChIP analysis shows that covalent modifications of
histone proteins associated with transcriptional activation
(H3K4me3,H3K9ac) are present throughout the histoneH4 locus
with the exception of the region around the TSS, which is almost
totally devoid of histone proteins (see, for example, total histone
H3 in Fig. 5A). Strikingly, these same two epigeneticmarks exhibit
cell cycle-dependent changes both 5= and 3= of the histone H4
locus that begin in late G1 phase and continue through S phase,
concurrent with increased histone H4 expression (Fig. 5A). Other
histone modifications that are normally associated with active
transcription (H4K12ac andH4K16ac) are, as expected, preferen-
tially detected in the distal 5= region of the histoneH4 promoter in
hES cells (Fig. 5B) and show highly distinct temporal changes
during the hES cell cycle. In contrast, the repressive epigenetic
markH3K27me3 is absent at the histoneH4 locus in synchronized
hES cells (Fig. 5B) yet is clearly detected at the GATA6 and OSX
loci that are not expressed (data not shown). The same dynamic
posttranslational modifications of histone proteins are detected at
the histone H3 locus at mid-S phase when maximal expression is
observed (Fig. 5C and D).
We also analyzed epigenetic marks at the histone H4 locus
during the cell cycle of normal fibroblasts, including H3K4me3,
which shows a notably different pattern than that observed in
asynchronous hES cells (Fig. 3B). ChIP analysis shows that high
levels of the active marks H3K4me3 and H4K12ac are present
throughout the histone H4 locus, including the regions around
theTSS, coding sequences, and 3= end (Fig. 5E and F). This pattern
represents a remarkable difference from that observed in hES cells
(Fig. 5A and B). As with hES cells, the repressive epigenetic mark
H3K27me3 is absent at the histone H4 locus in synchronized
WI-38 cells (Fig. 5F, bottom panel). The total histone H3 pattern
in synchronized normal somatic cells also shows a major differ-
ence with hES cells (Fig. 5F, bottom panel), and data normalized
to the total histone signal show a significant difference between
hES (Fig. 5G) andWI-38 (Fig. 5H) cells at the histone H4 locus at
mid-S phase when maximal expression is observed. Strikingly, in
hES cells the region around the TSS is devoid of these covalent
modifications, but in somatic cells these epigenetic marks remain
unchanged throughout the gene locus. These results indicate that
epigenetic marks for active chromatin at histone gene promoters
support cell cycle-dependent changes in histone gene expression
and occupancy of histone gene transcription factors in pluripo-
tent hES cells.
Three-dimensional chromatin architecture of the transcrip-
tionally active histone genes. The epigenetic changes that sup-
port stimulation of histone H4 gene transcription occur con-
comitant with the selective cell cycle-dependent recruitment of
the CDK2/cyclin E responsive coactivator p220NPAT that inter-
acts with the constitutively bound histone H4-specific tran-
scription factor HINFP to mediate the association of RNA pol
II with the histone H4 loci (26, 32, 37, 38, 40, 53, 57, 59, 61).
Our model postulates that the 5= and 3= regions of the histone
H4 locus interact through key HLB components that form a
protein-protein bridge. To test our model, we performed im-
munofluorescence microscopy and ChIP assays with represen-
tative HLB components involved in 5=-related transcriptional
functions and 3=-related processing functions (Fig. 6 and data
not shown) (see also reference 15). Immunofluorescence mi-
croscopy shows that the transcriptional component p220NPAT
colocalizes with both RNA pol II and the 3=-end processing
factor LSM11 (Fig. 6A). Importantly, ChIP results indicate that
3=-related factors LSM10, LSM11, FLASH, and SLBP interact
with both the histone promoter and the region encoding the
3=-end hairpin loop of the histone H4 and H3 mRNAs (Fig.
6B). We have also observed association of FLASH and SLBP
with similar regions of the histone H4 locus in the glioblastoma
cell line T98G (data not shown). Furthermore, using a proxim-
ity ligation assay (see Materials and Methods), we find a loop-
ing interaction between sequences upstream and downstream
of the histone H4 gene. Restriction fragments containing the 5=
and the 3= ends of the HIST2H4 gene show a higher ligation
frequency than that in a gene desert region near the histone
gene (Fig. 6D). Thus, dynamic G1/S-phase-related changes in
protein-DNA interactions that occur within an intricate mi-
replication-dependent histones colocalize to specific subnuclear foci known as histone locus bodies (HLBs) (21, 22). FLASH protein also localizes to HLBs (7, 23), is
required for transcription and 3=-end processing of histone mRNAs (2, 14, 28, 58), and interacts with histone gene loci (Fig. 6B and data not shown). The schematic
representation of components involved in 3=-end processing of histone pre-mRNAs was adapted from that of Dominski with permission (15). (D) Proximity ligation
assayof theHIST2H4gene.The toppanel shows a schematic of the genomicorganizationof thehumanhistoneH4gene andagenedesert region (GDR)near thehistone
H4 locus. The set of primers (open arrowheads) used for analyses and the FatI restriction sites (lines) are shown. The histone H4 locus (bottom panel) shows a higher
ligation frequency than a gene desert region, indicating a looping interaction between the 5= and 3= ends of the histone H4 gene (**, P
 0.01).
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croenvironment of active epigenetic marks and histone locus
body components together support a transcriptionally active
architectural chromatin configuration at the histone locus
(Fig. 6C).
DISCUSSION
Pluripotent stem cells must remodel chromatin architecture dur-
ing the cell cycle within a predominantly euchromatin back-
ground, in contrast to differentiated cells, where the genome is
architecturally and functionally organized as a composite of eu-
chromatin and gene-repressive heterochromatin. The accelerated
G1 phase of the cell cycle in hES cells demands rapid and selective
chromatin remodeling of S-phase-specific genes. We have estab-
lished that histone gene expression is the most prominent
S-phase-related transcriptional program in pluripotent human
embryonic stem (hES) cells, providing a paradigm for examining
cell cycle-dependent modifications in chromatin architecture
during self-renewal.
We show that dynamic gene regulatory interactions at the his-
tone H4 locus in hES cells occur in an “open” chromatin environ-
ment reflected by a nucleosome-free hypersensitive region at the
transcription start site (TSS) and an enrichment of active epige-
netic histone marks throughout the promoter and coding se-
quences (e.g., H3K4me3, H3K9ac) or selectively enriched in the
region upstream of the TSS (e.g., H4K12ac, H4K16ac). The entire
histone H4 gene locus appears to be devoid of H3K27me3 modi-
fication, which marks transcriptionally inactive chromatin. The
absence of H3K27me3 is consistent with the highly accessible
chromatin conformation of the H4 gene that is evidenced by its
pronounced nuclease sensitivity. A similar pattern of histone pro-
tein modifications was found for the histone H3 gene, suggesting
that this is a general mechanism for histone genes in hES cells.
Normally, active marks (e.g., H3K4me3, H3K9ac, H4K12ac, and
H4K16ac) are preferentially associatedwith locations at the 5= end
of the gene, while here we find that these marks are also selectively
enriched in the 3= region of the H4 and H3 genes that encode
sequences supporting mRNA maturation (Fig. 5 and 6). In con-
trast, in normal fibroblasts, besides a less pronounced association
of RNA pol II and HINFP, relatively constant levels of active epi-
genetic marks (e.g., H3K4me3 and H3K9ac) are present through-
out the histone H4 locus, thus indicating that a smaller fraction of
WI-38 cells are progressing through S phase. Hence, in hES cells
histone loci are distinctly organized in a hypersensitive configura-
tion that renders the 5= and 3= regions of the gene highly accessible
to themachinery required for transcript initiation and processing.
The functional efficiency afforded by this unique chromatin to-
pology may facilitate the accelerated G1-phase progression in hES
cells.
The activation of histone H4 gene expression at histone locus
bodies occurs concomitant with constitutive binding of the his-
tone H4-specific transcription factor HINFP and the selective cell
cycle-dependent recruitment of the CDK2/cyclin E responsive co-
activator p220NPAT, which together mediate the association of
RNA pol II (32, 37, 38, 40, 53, 57, 59, 61) with the histone H4 loci
(Fig. 6). Furthermore, p220NPAT associates with FLASH, LSM11,
and SLBP (2, 7, 23), indicating formation of a subnuclear macro-
molecular complex that supports both RNA transcript initiation
and processing. Our ChIP data, as well as the published literature,
indicate that selected HLB components bind to both 5= and 3=
regions of the histone H4 locus (2, 14, 28, 58) (Fig. 6 and data not
shown), thus potentially permitting a looped chromatin configu-
ration that supports the rapid induction of histone gene expres-
sion at the G1/S-phase transition in both human embryonic stem
cells and induced pluripotent stem cells.
The accelerated G1 phase of pluripotent (hES and iPS) cells
imposes major temporal constraints on the remodeling of chro-
matin as cellsmitotically divide and prepare for progression into S
phase. As pluripotent cells globally decondense chromosome
structure, selective accessibility to cell cycle-regulated genes must
be retained within a chromatin context exhibiting limited hetero-
chromatinization. This study reveals critical epigenetic parame-
ters that govern the establishment of chromatin structure condu-
cive for transcriptional induction of selected genomic loci at the
G1/S-phase transition. We find that the chromatin architecture of
highly expressed genes encoding histone proteins, which are re-
quired for packaging of newly replicated DNA during S phase, is
dynamically remodeled as cells progress rapidly from mitosis
through G1 into S phase. This active remodeling is accompanied
by an orchestrated recruitment of key gene regulatory factors, the
presence of a nucleosome-free region surrounding the TSS, and
atypical epigenetic marking of nucleosomes. We conclude that
self-renewal of pluripotent stem cells requires sequential recon-
figurations of the genome in rapid succession after the completion
ofmitosis within a highly contractedG1 phase—global chromatin
decondensation immediately followed by the assembly of sub-
nuclear microenvironments and the cell cycle stage-specific and
gene-selective local remodeling of chromatin structure to support
gene activation essential for S phase. Our study defines a novel
architectural dimension to control gene expression for self-re-
newal of human pluripotent stem cells.
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